The UJMT Global Consortium: building research capacity through mentored training

摘要 在过去五年中，由北卡罗来纳大学教堂分校组成的 UJMT 全球联盟 希尔、约翰霍普金斯大学、莫尔豪斯医学院和杜兰大学——支持 在低收入和中等收入国家 (LMIC) 的 28 个附属地点指导培训。从所有核心指标来看， UJMT奖学金计划非常成功：培训了132名博士生和博士后， 发表 109 篇手稿（其中 69 篇为第一作者），提交 204 份会议摘要，约 1.7 美元 筹集了 100 万美元的计划共同资金。我们一半以上的博士后研究员在毕业后已担任学术职务 完成计划；许多人已成功竞争研究经费，包括来自 NIH 的资助， 成为独立资助的调查员。在下一个资助周期（2017-2022），我们将扩展这些 进一步建设全球卫生研究能力的优势。第一，丰富美国和美国的人才储备。 LMIC 研究人员致力于解决全球健康问题。我们将招收博士生和 33个国内培养项目（即T32）和17个国际项目（即D43、 R25）隶属于我们的机构。我们将提供为期 12 个月的集中指导的实地机会， 将学员与各个科学领域和学科的专家联系起来。我们将继续培育 艾滋病毒/艾滋病、非传染性疾病、新发感染、癌症、心理健康、神经病学研究 疾病和妇女健康。二、我们将落地并迭代完善项目课程 根据学员、校友和导师的职业发展目标量身定制。我们将在此基础上 我们当前计划的活动（例如科学写作、网络研讨会、核心技能清单），同时增强新的 文化能力和全球研究道德等领域。我们还将投入资源来改善 我们计划中的指导，包括对学员和导师的支持。第三，我们将从战略上 分配资源支持中低收入国家站点能力建设。我们将竞争性地为研讨会和 短期课程、专业技能培训和支持长期研究基础设施的设备。我们会 与我们重点国家/地区现有的 D43 培训计划合作，最大限度地发挥我们的影响 投资。在能力较高的国家（例如马拉维、秘鲁、乌干达），我们将帮助协调和协调 正在进行的活动；在能力建设专用资源较少的国家（例如加纳、塞拉 Leone），我们将促进南南和南北伙伴关系，以查明差距并优先考虑需求 未来的赠款支持。我们的计划利用了一套独特的资源、培训师资和直接 福格蒂国际中心 2014 年制定的五个战略目标中的另外四个：建设研究 能力，支持实施科学，推进传染性和非传染性的研究 疾病，并建立伙伴关系以推进全球卫生研究。

ABSTRACT Over the past five years, the UJMT Global Consortium – comprising the University of North Carolina at Chapel Hill, Johns Hopkins University, Morehouse School of Medicine, and Tulane University – has supported mentored training at 28 affiliated sites in low- and middle-income countries (LMICs). By all core metrics, the UJMT fellowship program has been highly successful: 132 doctoral students and postdoctoral students trained, 109 manuscripts published (including 69 as first author), 204 conference abstracts presented, and ~$1.7 million in program co-funding raised. Over half of our postdoctoral fellows have taken academic positions after completing the program; many have successfully competed for research funding, including from the NIH, to become independently funded investigators. In the coming grant cycle (2017-2022), we will expand upon these strengths to further build capacity in global health research. First, we will enrich the pool of talented US and LMIC investigators committed to solving global health problems. We will recruit doctoral students and postdoctoral fellows from 33 domestic training programs (i.e., T32) and 17 international programs (i.e., D43, R25) affiliated with our institutions. We will provide 12-month, intensively mentored field opportunities that connect trainees with experts across a wide range of scientific areas and disciplines. We will continue to foster research in HIV/AIDS, non-communicable diseases, emerging infections, cancers, mental health, neurologic disorders, and women's health. Second, we will implement and iteratively improve a program curriculum tailored to the professional development goals of trainees, alumni, and mentors. We will build upon the activities of our current program (e.g., scientific writing, webinars, core skills checklists), while enhancing new areas such as cultural competency and global research ethics. We will also dedicate resources to improving mentorship within our program, including support for trainees and mentors alike. Third, we will strategically allocate resources to support LMIC site capacity building. We will competitively award funds for workshops and short courses, specialty skills training, and equipment to support long-term research infrastructure. We will collaborate with existing D43 training programs in our focus countries to maximize the impact of our investments. In countries with high capacity (e.g., Malawi, Peru, Uganda), we will help to align and coordinate ongoing activities; in countries with fewer dedicated resources for capacity building (e.g., Ghana, Sierra Leone), we will facilitate South-South and North-South partnerships to identify gaps and prioritize needs for future grant support. Our program leverages a unique set of resources, training faculty, and sites that directly further four of the five strategic goals set forth by the Fogarty International Center in 2014: building research capacity, supporting implementation science, advancing research on communicable and non-communicable diseases, and forming partnerships to advance global health research.